Replies to post #247853 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

We believe 80% will respond, meaning pretty much cured, and the rest will sleep better.

Simple logic since 80% of the population has the wild type SIGMAR1 and COMT genes.

See this biotech investing stuff is really easy when just read the numbers and trust the CEO who knows what he is doing.

[nidan7500]

F1lash:

So it seems to me the plan is to look at the small number of improved patients that should predictably show up in the current AD trial and see if they share some common markers that enhance response and then run a confirmatory trial with those parameters.

Exactly why the HH paper AD "super responders" are so important. These trials actually produce more than just 1's and 0's. 'AHHAAA' moments do happen.